Page 12 - Global Growth Pharmaceuticals & Biotech Stocks

UPDATED Aug 24, 2025

Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

3,048 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
4565
Nxera Pharma
JP¥950.001.7%-45.1%JP¥86.0bJP¥1,827.78PS2.8xE56.6%n/a
VRNA
Verona Pharma
US$105.56-0.2%295.5%US$9.1bUS$106.22PS41xE56.6%n/a
QNCX
Quince Therapeutics
US$1.63-3.6%147.0%US$87.6mUS$7.50PB7.5xE56.5%n/a
DVAX
Dynavax Technologies
US$10.50-2.7%-8.6%US$1.2bUS$23.25PS3.9xE56.5%n/a
OPT
Opthea
AU$0.600%23.7%AU$738.8mAU$1.09PS2307.7xE56.4%n/a
PHARM
Pharming Group
€1.1515.5%58.2%€788.6m€2.04PS2.7xE56.3%n/a
BCLI
Brainstorm Cell Therapeutics
US$0.653.1%-87.2%US$6.7mUS$20.68PE-0.6xE56.1%n/a
SVRA
Savara
US$3.163.9%-27.7%US$665.8mUS$8.36PB5.5xE56.1%n/a
VRCA
Verrica Pharmaceuticals
US$5.47-8.3%-80.6%US$51.6mUS$15.00PS3.5xE56.0%n/a
MSB
Mesoblast
AU$2.38-5.2%145.4%AU$3.0bAU$3.45PS348.4xE55.9%n/a
SCLX
Scilex Holding
US$18.874.4%-55.8%US$103.7mn/aPS2.3xE55.7%n/a
CCCC
C4 Therapeutics
US$2.616.1%-60.7%US$185.8mUS$15.80PS5.4xE55.6%n/a
PCRX
Pacira BioSciences
US$25.843.8%78.5%US$1.2bUS$29.00PS1.6xE55.5%n/a
DERM
Journey Medical
US$7.476.7%53.7%US$182.1mUS$11.50PS3.2xE55.0%n/a
CTXR
Citius Pharmaceuticals
US$1.351.5%-90.9%US$23.0mUS$6.00PB0.4xE54.7%n/a
ONC
Oncolytics Biotech
CA$1.420%8.4%CA$142.5mCA$5.13PB23.4xE54.6%n/a
MGTX
MeiraGTx Holdings
US$7.83-4.2%87.8%US$629.9mUS$27.33PS16.6xE54.6%n/a
ELUT
Elutia
US$2.093.5%-47.8%US$88.6mUS$6.50PS3.7xE54.6%n/a
BAYN
Bayer
€28.565.6%2.5%€28.1b€28.53PB0.9xE54.5%0.4%
LAB
Labiana Health
€3.920%26.5%€27.6mn/aPE108.9xE54.4%n/a
IMCR
Immunocore Holdings
US$32.930.2%-7.9%US$1.7bUS$62.00PS4.7xE54.4%n/a
JAZZ
Jazz Pharmaceuticals
US$123.114.5%8.1%US$7.5bUS$183.47PS1.8xE54.3%n/a
KURN
Kuros Biosciences
CHF 26.92-7.7%79.2%CHF 1.0bCHF 31.00PS10xE54.2%n/a
MDP
Medexus Pharmaceuticals
CA$2.87-2.7%18.1%CA$92.6mCA$6.71PE83.1xE54.2%n/a
Page 12 of 127